Researcher.Life Logo

ACS Medicinal Chemistry Letters : Impact Factor & More

eISSN: 1948-5875pISSN: 1948-5875

Aims and Scope of ACS Medicinal Chemistry Letters

ACS Medicinal Chemistry Letters is a peer-reviewed academic journal in the field of medicinal chemistry. Founded in 2009, this online journal is published monthly by the American Chemical Society. The Editor-in-Chief is Dennis C. Liotta (Emory University, Atlanta, Georgia, USA). Less

Key Metrics

CiteScore
6.6
Eigenfactor
0.01 - 0.05
Impact Factor
< 5
SJR
Q2Biochemistry
SNIP
0.93
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on ACS Medicinal Chemistry Letters

ACS Medicinal Chemistry Letters Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher AMER CHEMICAL SOC
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2010
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in ACS Medicinal Chemistry Letters ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in ACS Medicinal Chemistry Letters

Solid-Phase Synthesis and Biological Evaluation of Des-hydroxy Pseudouridimycin Analogs
  • 11 Mar 2026
  • ACS Medicinal Chemistry Letters
Ugi-Tetrazole-Derived α-Aminomethyl Scaffolds Reveal Unexpected Binding Modes in SARS-CoV-2 3CLpro
  • 4 Mar 2026
  • ACS Medicinal Chemistry Letters
Potent Neuronal Nicotinamide Adenine Dinucleotide-Boosting Tetrahydroquinoxalines: Structure–Activity Relationships and Early Drug Metabolism and Pharmacokinetics Evaluation
  • 4 Mar 2026
  • ACS Medicinal Chemistry Letters
Novel Compounds for Treating Huntington’s Disease
  • 4 Mar 2026
  • ACS Medicinal Chemistry Letters
Novel Compounds as MALT1 Inhibitors for Treating Cancer
  • 4 Mar 2026
  • ACS Medicinal Chemistry Letters
Discovery of Pyridopyrazine Inverse Agonists Targeting G Protein-Coupled Receptor 6
  • 3 Mar 2026
  • ACS Medicinal Chemistry Letters
Solid-Phase Synthesis and Biological Evaluation of Des-hydroxy Pseudouridimycin Analogs
  • 11 Mar 2026
  • ACS Medicinal Chemistry Letters
Ugi-Tetrazole-Derived α-Aminomethyl Scaffolds Reveal Unexpected Binding Modes in SARS-CoV-2 3CLpro
  • 4 Mar 2026
  • ACS Medicinal Chemistry Letters
Potent Neuronal Nicotinamide Adenine Dinucleotide-Boosting Tetrahydroquinoxalines: Structure–Activity Relationships and Early Drug Metabolism and Pharmacokinetics Evaluation
  • 4 Mar 2026
  • ACS Medicinal Chemistry Letters
Novel Compounds for Treating Huntington’s Disease
  • 4 Mar 2026
  • ACS Medicinal Chemistry Letters
Novel Compounds as MALT1 Inhibitors for Treating Cancer
  • 4 Mar 2026
  • ACS Medicinal Chemistry Letters
Discovery of Pyridopyrazine Inverse Agonists Targeting G Protein-Coupled Receptor 6
  • 3 Mar 2026
  • ACS Medicinal Chemistry Letters

FAQs on ACS Medicinal Chemistry Letters